Sangamo Therapeutics, Inc (SGMOQ) stock
SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.10−0.01 (-8.17%)
Close on Oct 19, 2026Market cap $39.43MP/E –Yield –
Sangamo Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Sangamo Therapeutics's enterprise value was $5.03M on Oct 19, 2026, against $96.92M a year earlier. Over the last 5 years it ranged from -$82.14M to $766.31M, with a median of $96.92M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $5.03M | -93.2% |
| 2025 | Dec 31, 2025 | $74.52M | -53.1% |
| 2024 | Dec 31, 2024 | $158.75M | – |
| 2023 | Dec 29, 2023 | -$39.56M | -125.4% |
| 2022 | Dec 30, 2022 | $156.00M | -76.1% |
| 2021 | Dec 31, 2021 | $652.94M | -51.6% |
| 2020 | Dec 31, 2020 | $1.35B | +143.1% |
| 2019 | Dec 31, 2019 | $554.85M | -21.9% |
| 2018 | Dec 31, 2018 | $710.55M | -47.3% |
| 2017 | Dec 29, 2017 | $1.35B | +620.0% |
| 2016 | Dec 30, 2016 | $187.41M | -69.0% |
| 2015 | Dec 31, 2015 | $605.20M | -41.1% |
| 2014 | Dec 31, 2014 | $1.03B | +40.3% |
| 2013 | Dec 31, 2013 | $732.91M | +182.1% |
| 2012 | Dec 31, 2012 | $259.81M | +302.4% |
| 2011 | Dec 30, 2011 | $64.57M | – |
See a number that looks wrong?